DK124942B - Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.

Info

Publication number
DK124942B
DK124942B DK464168AA DK464168A DK124942B DK 124942 B DK124942 B DK 124942B DK 464168A A DK464168A A DK 464168AA DK 464168 A DK464168 A DK 464168A DK 124942 B DK124942 B DK 124942B
Authority
DK
Denmark
Prior art keywords
preparation
acid addition
addition salts
analogous process
alkanolamine derivatives
Prior art date
Application number
DK464168AA
Other languages
Danish (da)
English (en)
Inventor
R Howe
L Smith
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of DK124942B publication Critical patent/DK124942B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK464168AA 1967-09-27 1968-09-26 Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf. DK124942B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43927/67A GB1199037A (en) 1967-09-27 1967-09-27 Alkanolamine Derivatives

Publications (1)

Publication Number Publication Date
DK124942B true DK124942B (da) 1972-12-11

Family

ID=10430973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464168AA DK124942B (da) 1967-09-27 1968-09-26 Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.

Country Status (16)

Country Link
US (1) US3712927A (ru)
JP (1) JPS5220459B1 (ru)
AT (3) AT298456B (ru)
BE (1) BE721560A (ru)
BR (1) BR6802575D0 (ru)
DE (1) DE1793511A1 (ru)
DK (1) DK124942B (ru)
FR (1) FR333F (ru)
GB (1) GB1199037A (ru)
IE (1) IE32739B1 (ru)
IL (1) IL30764A (ru)
NL (1) NL6813616A (ru)
NO (1) NO123893B (ru)
PL (1) PL71423B1 (ru)
SE (1) SE357361B (ru)
SU (1) SU385433A3 (ru)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311521A (en) * 1970-02-13 1973-03-28 Ici Ltd Alkanolamine derivatives
SE354851B (ru) * 1970-02-18 1973-03-26 Haessle Ab
US3864398A (en) * 1972-05-01 1975-02-04 Teikoku Hormone Mfg Co Ltd Process for the preparation of acylamino alkanol derivatives
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
DE2324584A1 (de) * 1972-06-08 1974-01-10 Ciba Geigy Ag Neue amine und verfahren zu ihrer herstellung
SE386892B (sv) * 1972-07-06 1976-08-23 Haessle Ab Forfarande for framstellning av oxaminoforeningar
US4083992A (en) * 1972-12-15 1978-04-11 Imperial Chemical Industries Limited Alkanolamine derivatives
US4171374A (en) * 1972-12-15 1979-10-16 Imperial Chemical Industries Limited Alkanolamine derivatives
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
US4131685A (en) * 1972-12-15 1978-12-26 Imperial Chemical Industries Limited Pharmaceutical compositions and uses of alkanolamine derivatives
US4167581A (en) * 1972-12-15 1979-09-11 Imperial Chemical Industries Limited Alkanolamine derivatives and pharmaceutical compositions and uses thereof
US4084002A (en) * 1973-02-28 1978-04-11 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
US4016202A (en) * 1973-02-28 1977-04-05 Boehringer Ingelheim Gmbh 1-Phenoxy-2-hydroxy-3-alkynylamino-propanes and salts thereof
US4016286A (en) * 1973-02-28 1977-04-05 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and their use as adrenolytics and hypotensives
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
US3957870A (en) * 1973-07-19 1976-05-18 Imperial Chemical Industries Limited Organic compounds
US4039683A (en) * 1973-08-21 1977-08-02 Merck Patent Gesellschaft Mit Beschrankter Haftung Phenoxypropionic acid derivatives and pharmaceutical preparations containing same
US4239700A (en) * 1978-10-10 1980-12-16 Texaco Development Corp. Isatoic anhydride derivatives and use as chain-extenders
DE3015991A1 (de) 1980-04-25 1981-11-05 C.H. Boehringer Sohn, 6507 Ingelheim Neue 1-aryloxy-3-alkylamino-2-propanole und verfahren zur ihrer herstellung
DE3133678A1 (de) * 1981-08-26 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Neue l-aryloxy-3-alkylamino-2-propanole und verfahren zu ihrer herstellung
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
FR2555179B1 (fr) * 1983-11-21 1986-11-21 Carpibem Nouveaux (carbethoxy-2 furyl- ou benzofuryl-carboxamido-4 phenoxy)-1 amino-3 propanols-2 : leurs preparations et leurs applications en therapeutique
JPS6193417U (ru) * 1984-11-24 1986-06-17
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
DE3640829A1 (de) * 1986-11-28 1988-06-09 Boehringer Ingelheim Kg Neue 1-aryloxy-3-amino-2-propanole, ihre herstellung und verwendung
US5202487A (en) * 1988-09-13 1993-04-13 L'oreal 2-substituted para-aminophenols and their use for dyeing keratinous fibres
FR2637282B1 (fr) * 1988-09-13 1990-12-07 Oreal Para-aminophenols 2-substitues et leur utilisation pour la teinture des fibres keratiniques
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
EP0901459B1 (en) 1996-04-09 2005-06-29 Nps Pharmaceuticals, Inc. Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
UY24949A1 (es) 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
FR333F (ru) 1970-10-26
JPS5220459B1 (ru) 1977-06-03
NL6813616A (ru) 1969-03-31
AT298456B (de) 1972-05-10
GB1199037A (en) 1970-07-15
NO123893B (ru) 1972-01-31
AT291968B (de) 1971-08-10
PL71423B1 (en) 1974-06-29
IL30764A0 (en) 1968-11-27
IE32739B1 (en) 1973-11-14
IE32739L (en) 1969-03-27
IL30764A (en) 1972-11-28
US3712927A (en) 1973-01-23
SU385433A3 (ru) 1973-05-29
AT298455B (de) 1972-05-10
BE721560A (ru) 1969-03-27
BR6802575D0 (pt) 1973-04-26
SE357361B (ru) 1973-06-25
DE1793511A1 (de) 1972-03-16

Similar Documents

Publication Publication Date Title
DK124942B (da) Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.
DK119153B (da) Analogifremgangsmåde til fremstilling af 3-benzoyl-phenyleddikesyre-derivater eller salte deraf.
DK122879B (da) Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.
DK124824B (da) Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.
DK123022B (da) Analogifremgangsmåde til fremstilling af amino-monohalogen-phenylethanolaminer eller syreadditionssalte deraf.
DK132411B (da) Analogifremgangsmåde til fremstilling af pyrrylaminoketonderivater eller syreadditionssalte deraf.
DK129238B (da) Fremgangsmåde til fremstilling af morphinanderivater eller syreadditionssalte deraf.
DK118187B (da) Fremgangsmåde til fremstilling af indolderivater eller syreadditionssalte deraf.
DK119059B (da) Fremgangsmåde til fremstilling af 2-nitro-imidazolderivater eller syreadditionssalte deraf.
DK137193B (da) Analogifremgangsmåde til fremstilling af naphthacenderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK139940B (da) Analogifremgangsmåde til fremstilling af benzimidazolforbindelser eller syreadditionssalte eller metaladditionsforbindelser deraf.
DK129924B (da) Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf.
DK126327B (da) Analogifremgangsmåde til fremstilling af derivater af p-aminoalkylbenzensulfonamid eller syreadditionssalte deraf.
DK120998B (da) Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.
DK127331B (da) Analogifremgangsmåde til fremstilling af aryloxyisoalkyl-Δ<2>-imidazoliner eller syreadditionssalte heraf.
DK120133B (da) Analogifremgangsmåde til fremstilling af piperazinderivater eller syreadditionssalte deraf.
DK130587B (da) Analogifremgangsmåde til fremstilling af difenylpyridazoner eller syreadditionssalt deraf.
DK125129B (da) Analogifremgangsmåde til fremstilling af oximderivater eller syreadditionssalte deraf.
DK137674B (da) Analogifremgangsmåde til fremstilling af monophenylsubstituerede oxazoler eller syreadditionssalte deraf.
DK130288B (da) Analogifremgangsmåde til fremstilling af alkanolaminderivater eller syreadditionssalte deraf.
DK126781B (da) Analogifremgangsmåde til fremstilling af pyrrolidinoguanidinforbindelser eller syreadditionssalte deraf.
DK128813B (da) Analogifremgangsmåde til fremstilling af basisk substituerede thiophthalaner eller syreadditionssalte deraf.
DK125921B (da) Analogifremgangsmåden til fremstilling af thiazepinderivater eller syreadditionssalte deraf.
DK123097B (da) Fremgangsmåde til fremstilling af kasugamycinderivater eller syreadditionssalte deraf.
DK121375B (da) Analogifremgangsmåde til fremstilling af N-aminoalkylbenzazacycloalkanderivater eller syreadditionssalte heraf.